Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
392,193,323
-
Total 13F shares
-
103,355,148
-
Share change
-
-188,370
-
Total reported value
-
$7,664,869,633
-
Put/Call ratio
-
79%
-
Price per share
-
$74.16
-
Number of holders
-
267
-
Value change
-
+$5,330,131
-
Number of buys
-
136
-
Number of sells
-
128
Institutional Holders of DEXCOM INC - Common Stock (DXCM) as of Q1 2018
As of 31 Mar 2018,
DEXCOM INC - Common Stock (DXCM) was held by
267 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
103,355,148 shares.
The largest 10 holders included
PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, VANGUARD GROUP INC, JANUS HENDERSON GROUP PLC, WELLINGTON MANAGEMENT GROUP LLP, BAILLIE GIFFORD & CO, Capital World Investors, MORGAN STANLEY, BlackRock Inc., and BROWN ADVISORY INC.
This page lists
267
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.